A Comparison of Insulin Adherence in Patients with Type 2 Diabetes Initiating Therapy with Insulin Detemir in a Pen Device or NPH Insulin in a Vial

被引：0
|
作者：
Buysman, Erin K.
Conner, Christopher
Liu, Fang
Aagren, Mark
Bouchard, Jonathan
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2363-PO
引用
收藏
页码：A628 / A628
页数：1
相关论文
共 50 条
  • [31] Intensified insulin therapy of type 2 diabetes mellitus: Insulin glargine vs. insulin detemir as basal insulin
    Jungmann, Eckart
    DIABETES, 2006, 55 : A118 - A118
  • [32] Basal insulin therapy in type 2 diabetes - 28-week comparison of insulin glargine (HOE 901) and NPH insulin
    Rosenstock, J
    Schwartz, SL
    Clark, CM
    Park, GD
    Donley, DW
    Edwards, MB
    DIABETES CARE, 2001, 24 (04) : 631 - 636
  • [33] Insulin therapy among type 2 diabetes patients: Impact of conversion to a pen device on adherence, hypoglycemic events, and costs
    Lee, W. C.
    Balu, S.
    Cobden, D.
    Joshi, A., V
    Pashos, C. L.
    VALUE IN HEALTH, 2006, 9 (06) : A187 - A187
  • [34] Initiating insulin in patients with type 2 diabetes
    Lau, Adrian N. C.
    Tang, Terence
    Halapy, Henry
    Thorpe, Kevin
    Yu, Catherine H. Y.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2012, 184 (07) : 767 - 776
  • [35] A randomized controlled trial of insulin detemir versus insulin NPH for the treatment of pregnant women with gestational diabetes and type 2 diabetes
    Herrera, Kimberly
    Rosenn, Barak
    Foroutan, Janelle
    Bimson, Brianne
    Al Ibraheemi, Zainab
    Brustman, Lois
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 212 (01) : S320 - S320
  • [36] Lower rate of hypoglycaemia but comparable glycaemic control with insulin detemir compared to NPH insulin in patients with type 1 diabetes
    Hermansen, K.
    Heller, S.
    Andersen, M.
    Russell-Jones, D. L.
    DIABETOLOGIA, 2009, 52 : S359 - S359
  • [37] Insulin detemir is associated with lower risk of hypoglycemia compared to NPH insulin in people with Type 1 diabetes
    Kolendorf, K
    Prasek, M
    Santeusanio, F
    Philotheou, A
    Gall, MA
    Heller, S
    DIABETOLOGIA, 2004, 47 : A329 - A329
  • [38] Insulin detemir improves glycemic control and reduces the risk of weight gain in comparison to NPH insulin in diabetes
    Draeger, E
    Kim, H
    OBESITY RESEARCH, 2004, 12 : A43 - A43
  • [39] Insulin detemir is associated with lower risk of hypoglycemia compared to NPH insulin in people with type 1 diabetes
    Kolendorf, K
    Pavlic-Renar, I
    San-Teusanio, F
    Philotheou, A
    Gall, MA
    Heller, S
    DIABETES, 2004, 53 : A130 - A131
  • [40] Insulin Detemir Reduces Hypoglycemic Risk at Comparable HbAfc Values Compared to NPH Insulin in Patients with Type 1 Diabetes
    Hermansen, Kjeld
    Heller, Simon
    Andersen, Marc
    Russell-Jones, David L.
    DIABETES, 2009, 58 : A529 - A530
12345